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FIRST CLINICAL CASE REPORTAn unusual cause of necrosis and nasal septum perforation after
septoplasty: Enterobacter cloacaeM. Binar1, F. Arslan1, H. Tasli1, O. Karakoc1, A. Kilic2 and U. Aydin1
1) Department of Otolaryngology, Head and Neck Surgery and 2) Department of Medical Microbiology, Gulhane Military Medical Academy, Ankara, TurkeyAbstractA 20-year-old man with nasal obstruction underwent septoplasty due to nasal septal deviation. Nasal packs were inserted at the end of
surgery and removed 48 hours after surgery. Twenty-four hours after removal of nasal packs, there was necrosis in both sides of septal
mucosa and in bilateral inferior turbinates. Nasal swab culture was performed from both nasal cavities. Enterobacter cloacae was isolated
from samples. Two weeks after surgery, nasal septum perforation was unavoidable. To our knowledge, this is the ﬁrst case in literature
describing septal mucosal necrosis caused by this pathogen after septoplasty. Mucosal necrosis and perforation as septoplasty
complications should be kept in mind, the result of causes both common and, as in the present case, unusual.
New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
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E-mail: mbinar4@yahoo.comIntroductionSeptoplasty is one of the most performed surgical procedures
in rhinology practice, and complications after this surgery are
well known. Bleeding, septal hematoma, septal perforation and
synechial bands can occur after surgery, although most of these
are easy for surgeons to overcome [1,2]. Rare but severe
complications such as toxic shock syndrome, endocarditis,
osteomyelitis, meningitis and cavernous sinus thrombosis have
been described after septoplasty [3,4]. Prophylactic antibiotics
are usually sufﬁcient for preventing postoperative infections,
but sometimes different pathogens can cause difﬁcult situations
for both surgeon and patient. In this report, we present the
case of a patient who underwent septoplasty, which was
complicated by tissue necrosis and nasal septal perforation by
an unusual pathogen, Enterobacter cloacae.w Microbe and New Infect 2015; 8: 150–153
w Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
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p://dx.doi.org/10.1016/j.nmni.2015.07.002Case ReportA 20-year-old man with severe nasal obstruction applied to
our Otolaryngology, Head and Neck Surgery Department.
After rhinoscopic examination and detailed endoscopic eval-
uation, septal deviation was diagnosed and a septoplasty pro-
cedure offered. The surgery was performed under general
anaesthesia following standard sterilization procedures. A
Killian incision was preferred for septal deviation, and nasal
packs (Merocel standard nasal dressing; Medtronic Xomed,
Jacksonville, FL, USA) were inserted into the nasal cavities at
the end of surgery. A single dose of 1 g cefazolin iv was
administrated on the evening of the day of the operation, and a
2 × 500 mg dose of cefuroxime axetil was provided for the
next 7 days. Forty-eight hours after surgery, the Merocel packs
were removed. The ﬁrst thing we observed after the packs’
removal was oedema of the nasal mucosa and turbinates, as is
routinely seen after nasal septal surgery. No perforation of the
nasal septum was observed. Twenty-four hours after removal,
there were nasal purulent discharge and color change of mu-
cosa to greyish on both sides of septum and in the inferior
turbinates (Fig. 1A, B).European Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
FIG. 1. (A) Necrosis of left septal mucoperichondrial ﬂap. (B) Necrosis of right nasal septal mucosa and inferior turbinate. (C) Nasal septal perfo-
ration, left nasal passage, immediately after removal of Doyle splint.
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samples from necrotic septal mucosa and left inferior turbinate
for histopathologic and microbiologic analysis. During 5 days we
continued to apply debridement and cleaning of nasal passages by
suction, while also supporting the patient with systemic antibiotic
therapy (cefazolin 1 g iv twice a day). Finally, 8 days after surgery
(at which time there was still no perforation), we inserted a sil-
icone nasal splint to prevent nasal synechia. The histopathologic
analysis of samples was reported as inﬂammation and necrosis,
and Enterobacter cloacae was identiﬁed by the BD Phoenix
automated system (BD Diagnostic Systems, Sparks, MD, USA).
Antibiotic susceptibility was performed by the BD Phoenix
automated system and was interpreted according to Clinical
Laboratory Standards Institute criteria. E. cloacae was suscep-
tible to trimethoprim/sulfamethoxazole (minimum inhibitory
concentration (MIC) 1/19 mg/L), meropenem (MIC 0.5 mg/
L), imipenem (MIC 1 mg/L), gentamicin (MIC 2 mg/L),
ertapenem (MIC 0.25 mg/L), ciproﬂoxacin (MIC 0.5 mg/L),
ceftriaxone (MIC 1 mg/L), ceftazidime (MIC 1 mg/L), cefe-
pime (MIC 1 mg/L) and amikacin (MIC 8 mg/L) and was
resistant to cefoxitin (MIC >16 mg/L), cefazolin (MIC >8 mg/L)
and ampicillin-sulbactam (MIC >8/4 mg/L). We thus changed
the antibiotic to ciproﬂoxacin because Enterobacter are intrin-
sically resistant to ampicillin, amoxicillin, amoxicillin-clavulanate,
ﬁrst-generation cephalosporins and cefoxitin owing to the
production of constitutive AmpC β-lactamase. After a week we
removed the silicon splints and ﬁnally observed normal, healthy
color of mucosa on inferior turbinates, but unfortunately with
perforation of the anterior septum 15 × 10 mm in diameter
(Fig. 1C).DiscussionBecause septoplasty is one of the most common surgical pro-
cedures in rhinology practice, complications of this surgery areNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf
This is an open access artialso variable. Surgeon experience, attentive surgery and exact
preoperative preparation usually prevent complications.
Continuous complaints of subjective nasal obstruction,
bleeding, septal hematoma, septal perforation and synechial
bands are often present after surgery; most of these are easy to
overcome [1,2].
Mucous membranes are traumatized during septoplasty, an
invitation to infections and bacteraemia by the vascular route
within the nasal mucous membranes [2]. In the study of Makitie
et al., the rate of local infection and septal abscess after sep-
toplasty was 12%; on the other hand, Yoder and Weimert
showed minor nasal infections only in ﬁve patients (0.48%) in a
large nasal septal surgery series comprising 1040 patients [3,5].
Rare but severe complications such as toxic shock syndrome,
endocarditis, osteomyelitis, meningitis and cavernous sinus
thrombosis may also occur after surgery. Most of these serious
infections are caused by Staphylococcus aureus, which is found
in normal nasal microbial ﬂora in approximately 50% of in-
dividuals [3,4,6].
Okur et al. investigated the incidence of bacteraemia during
septoplasty and septorhinoplasty procedures by analysing the
nasal and blood cultures taken preoperatively, intraoperatively
and postoperatively [7]. In cultures taken from nasal swabs,
coagulase-negative staphylococci were the most frequently
isolated bacteria (65%), followed by S. aureus with or without
other organisms (35%). Even though all preoperative and
postoperative blood culture specimens were negative, bacterial
growth was observed in ﬁve of 60 blood cultures taken
intraoperatively, three of which were coagulase-negative
staphylococci, one Escherichia coli and the other S. aureus.
They also mentioned that patients with demonstrated bacter-
aemia from intraoperative blood cultures did not show any
clinical sign of focal or systemic infection. In the other study,
isolated bacteria from blood cultures taken immediately after
surgery and 48 hours after surgery were similar to those that
were found in nasal smear cultures except two pathogens,of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 8, 150–153
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
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from blood cultures [8].
The use of prophylactic antibiotics in rhinologic surgery is
preferred by most physicians. However, the most recent
studies have demonstrated that there is still not strong evidence
to use antibiotics for every septal surgery. Caniello et al. did not
observe signiﬁcant differences in the their study groups—
patients who did or did not receive antibiotics after sur-
gery— for fever, purulent secretion and infections; therefore,
they suggested that nasal surgeries are clean contaminated and
do not need antibiotic prophylaxis because of low infection risk
[9]. The study of Ricci and D’Ascanio, consisting of 630 pa-
tients, showed that septoplasty procedures that used antibiotics
did not differ from those that did not in terms of infection
development [10].
Antibiotics are usually sufﬁcient for preventing infections,
but sometimes different pathogens can cause difﬁcult situations
for both surgeon and patient. E. cloacae is a facultative Gram-
negative proteobacterium belonging to the Enterobacteriaceae
family [11]. Bacteria of the Enterobacter genus are widely found
in nature; they are saprophytic in the environment, as they are
found in soil and sewage, and are also part of the commensal
enteric ﬂora of the human gastrointestinal tract. Enterobacter
cloacae, Enterobacter agglomerans and Enterobacter aerogenes
have been found to multiply faster in 5% dextrose than
Escherichia coli, Pseudomonas aeruginosa, Proteus spp. and Staph-
ylococcus spp. Enterobacter spp. now pose a much broader
nosocomial problem, causing a wide variety of infections.
Overviews of Enterobacter infections suggest that common
reservoirs for the organism include the urinary, respiratory and
gastrointestinal tracts, in addition to surgical and burn wounds
[12,13].
In the study of Hulterstrom et al., the most prevalent ﬁnding
in nasal septal mucosa was aerobic irregular Gram-positive rods
suggestive of Corynebacterium (58%); coagulase-negative staph-
ylococci colonization was 53%, S. aureus 13% and Enter-
obacteriaceae 3% [14]. The study of Frank et al. showed that
Proteobacteria (e.g. Enterobacter spp.) was 4% in anterior nares
swabs in healthy adults [15].
Yoo et al. performed a retrospective review of 363
consecutive adult patients who underwent preoperative nasal
swab testing and rhinoplasty or septorhinoplasty (174 primary
rhinoplasty, 189 revision rhinoplasty). In the study design, ﬁrst
they identiﬁed endogenous nasal ﬂora preoperatively, then
pathogenic bacteria treated with culture-directed antibiotics.
They found that 78.2% of patients had normal ﬂora; 10.7% had
S. aureus; and 0.28% had methicillin-resistant S. aureus. In 7.4%
of patients, faecal coliforms including Escherichia coli, Enter-
obacter spp., and Citrobacter spp. were found. They stated that
age, sex, smoking, the use of oral contraceptives and theNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licepresence of seasonal allergies did not signiﬁcantly change the
nasal ﬂora or the postoperative infection rate. Patients with
adult acne were found to have an increased incidence of
colonization with faecal coliforms (43.8%; p <0.001) [16].
We did not assess patients’ nasal ﬂora before surgery, so we
did not perform any tests learn whether E. cloacae was a
member of patient’s nasal ﬂora. Nevertheless, we cannot
exclude the possibility that the infection might have developed
by means of horizontal transmission. In the prospective
epidemiologic study of Flynn et al. on patients undergoing one
type of surgery, most Enterobacter infections developed in pa-
tients who already had Enterobacter spp. as part of their
endogenous ﬂora. Horizontal transmission was responsible for
only two of 12 Enterobacter infections [17].
To our knowledge, the present case is the ﬁrst in the liter-
ature to describe E. cloacae as a cause of necrosis of the nasal
septal mucosa. We could not achieve progress by using anti-
biotics (single-dose cefazolin iv on the surgery day and cefur-
oxime axetil po on the following days), which many physicians
usually prefer after septoplasty. After isolation of Enterobacter
infection, we changed the antibiotic to ciproﬂoxacin because
the bacterium has an intrinsic resistance to ampicillin, amoxi-
cillin and cephalosporins [18]. Many intensive care physicians
would agree that the excessive use of broad-spectrum antibi-
otics, especially cephalosporin agents, has contributed to the
emerging prominence of Enterobacter spp. as important noso-
comial pathogens [19]. Even 2 days of cefazolin prophylaxis
before surgery was associated with a signiﬁcantly higher rate of
Enterobacter colonization than that seen in patients who did not
receive antibiotic prophylaxis (p 0.001) [17].
Most isolates of E. cloacae are susceptible to trimethoprim/
sulfamethoxazole, ﬂuoroquinolones, chloramphenicol, tetracy-
clines, aminoglycosides, piperacillin-tazobactam and carbape-
nems. If they produce extended-spectrum β-lactamase, they
become resistant to fourth-generation cephalosporins; there
are thus concerns about spread of carbapenemase-producing
E. cloacae [20]. Although ciproﬂoxacin treatment was one of
the best alternatives for his pathogen, nasal septum perforation
was unavoidable. There are also some reports explaining low
resistance to ﬂuoroquinolones by the mechanisms consisting of
target mutations for DNA gyrase and topoisomerase IV,
decreasing permeability or augmenting expression of efﬂux
pumps [20,21].
What was the mechanism of necrosis in the present case?
E. cloacae strains produce enterotoxins, α-hemolysin and thiol-
activated pore-forming cytotoxins similar to Shiga-like toxin II;
thus, it involves curli ﬁmbriae in the formation of bioﬁlms.
Genes of type III secretion system, which delivers toxins into
the host cells, were found in E. cloacae strains and contribute to
its pathogenesis [20].European Society of Clinical Microbiology and Infectious Diseases, NMNI, 8, 150–153
nses/by-nc-nd/4.0/)
NMNI Binar et al. Necrosis and septum perforation after septoplasty 153ConclusionNecrosis resulting in nasal septum perforation after septoplasty
is infrequent. It is surprising that unusual pathogens such as
Enterobacter cloacae, which probably has low colonization in
nasal mucosa, can cause this bothersome situation. Antibiotic
prophylaxis with ﬁrst- or second-generation cephalosporins
was not adapted in this case because E. cloacae is known to be
naturally resistant to these agents. All rhinology surgeons must
be aware of different infectious pathogens in the aetiology of
necrosis after septoplasty to prevent further complications
such as nasal septal perforation. In case of postoperative
infection, nasal swab cultures must be taken, and oral wide-
spectrum antibiotics should be administrated until the speciﬁc
pathogen is identiﬁed by microbiologic analysis.Conﬂict of InterestNone declared.References[1] Ketcham AS, Han JK. Complications and management of septoplasty.
Otolaryngol Clin N Am 2010;43:897–904.
[2] Bloom JD, Kaplan SE, Bleier BS, Goldstein SA. Septoplasty complica-
tions: avoidance and management. Otolaryngol Clin N Am 2009;42:
463–81.
[3] Makitie A, Aaltonen LM, Hytonen M, Malmberg H. Postoperative
infection following nasal septoplasty. Acta Otolaryngol Suppl 2000;543:
165–6.
[4] Bandhauer F, Buhl D, Grossenbacher R. Antibiotic prophylaxis in
rhinosurgery. Am J Rhinol 2002;16:135–9.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf
This is an open access arti[5] Yoder MG, Weimert TA. Antibiotics and topical surgical preparation
solution in septal surgery. Otolaryngol HeadNeck Surg 1992;106:243–4.
[6] Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A,
Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus
infections. Lancet Infect Dis 2005;5:751–62.
[7] Okur E, Yildirim I, Aral M, Ciragil P, Kiliç MA, Gul M. Bacteremia
during open septorhinoplasty. Am J Rhinol 2006;20:36–9.
[8] Kaygusuz I, Kizirgil A, Karlidag T, Yalçin S, Keles E, Yakupogullari Y,
et al. Bacteremia in septoplasty and septorhinoplasty surgery. Rhinol-
ogy 2003;41:76–9.
[9] Caniello M, Passerotti GH, Goto EY, Voegels RL, Butugan O. Antibi-
otics in septoplasty: is it necessary? Rev Bras Otorrinolaringol 2005;71:
734–8.
[10] Ricci G, D’Ascanio L. Antibiotics in septoplasty: evidence or habit? Am
J Rhinol Allergy 2012;26:194–6.
[11] Liu WY, Wong CF, Chung KM, Jiang JW, Leung FC. Comparative
genome analysis of Enterobacter cloacae. PLoS One 2013;8:e74487.
[12] Ristuccia PA, Cunha BA. Enterobacter. Infect Control 1985;6:124–8.
[13] Rotter G, Rice D, Ofﬂee L. Enterobacter. J Nosocomial Infect 1988;5.
9–10, 17–18.
[14] Hulterstrom AK, Sellin M, Berggren D. The microbial ﬂora in the nasal
septum area prone to perforation. APMIS 2012;120:210–4.
[15] Frank DN, Feazel LM, Bessesen MT, Price CS, Janoff EN, Pace NR. The
human nasal microbiota and Staphylococcus aureus carriage. PLoS One
2010;5:e10598.
[16] Yoo DB, Peng GL, Azizzadeh B, Nassif PS. Microbiology and antibiotic
prophylaxis in rhinoplasty: a review of 363 consecutive cases. JAMA
Facial Plast Surg 2015;17:23–7.
[17] Flynn DM, Weinstein RA, Nathan C, Gaston MA, Kabins SA. Patients’
own ﬂora as the source of ‘nosocomial’ Enterobacter in cardiac surgery.
J Infect Dis 1987;156:363–8.
[18] Keller R, Pedroso MZ, Ritchmann R, Silva RM. Occurrence of
virulence-associated properties in Enterobacter cloacae. Infect Immun
1998;66:645–9.
[19] Weinstein RA. Endemic emergence of cephalosporin resistant Enter-
obacter: relation to prior therapy. Infect Control 1986;7:120–3.
[20] Mezzatesta ML, Gona F, Stefani S. Enterobacter cloacae complex: clinical
impact and emerging antibiotic resistance. Future Microbiol 2012;7:
887–902.
[21] Ruiz J. Mechanisms of resistance to quinolones: target alterations,
decreased accumulation and DNA gyrase protection. J Antimicrob
Chemother 2003;51:1109–17.of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 8, 150–153
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
